CannPal
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
45a Bay St L 3, Double Bay, New South Wa...Phone Number
+61 261083622Website
www.cannpal.comRevenue
<$5 MillionStock Symbol
CP1Industry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CannPal
CannPal Animal Therapeutics is a global leader in developing cannabinoid-derived therapeutic products aimed at veterinarians and pet owners. The company focuses on creating clinically validated and standardized therapeutics for treating pain, inflammation, mood, and dermatological conditions in animals. As a subsidiary of AusCann Group Holdings, CannPal is dedicated to addressing unmet needs in the animal health market through innovative, plant-based solutions. Their research emphasizes the benefits of medical cannabis for companion animals, ensuring safety and ethical treatment.Explore more
CannPal Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CannPal your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
CannPal, which may be a good buyer, showed buying intent in Masked Content Topic
Check if CannPal has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once CannPal has new funding data
Congratulate Masked Content for being promoted to Masked Content at CannPal
Click to see if CannPal had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when CannPal launches new products
Earning: See what the market has to say on CannPal recently announced quarterly report
Check out if CannPal is spiking on competitors!
Recommended Actions
Find VP level buyers at CannPal
Find more new buyers
Compare Similar Companies to CannPal
Compare insights from companies similar to CannPal, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CannPal is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CannPal is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CannPal.
CannPal Tech Stack
A closer look at the technologies used by CannPal
See more technologies
CannPal News & Media
CBD Substantially Improves Atopic Dermatitis Symptoms in Dogs
Key Highlights A hemp-derived CBD nutraceutical for dogs developed by an Australian Animal Health Company, has substantially Improved Atopic Dermatitis symptoms in a canine clinical study; The product (DermaCann®) substantially reduced CADESI-4 scoring in dogs with Atopic Dermatitis, by...Introducing CannPal Animal Therapeutics (ASX:CP1), The Stock That Dropped 15% In The Last Year
It's easy to match the overall market return by buying an index fund. But if you buy individual stocks, you can do...CannPal Enters into Exclusive Licencing Agreement with CSIRO
Key Highlights CannPal has completed its evaluation into the microencapsulation of hemp-derived oils with the Commonwealth Scientific and Industrial Research Organisation (CSIRO); CSIRO has granted CannPal an exclusive global licence to commercialise their patented MicroMAX®...CannPal Enters into Exclusive Licencing Agreement with CSIRO
Animal health company CannPal Animal Therapeutics Limited (ASX:CP1) ("CannPal" or "the Company") is pleased to announce that following an 18 month evaluation, it has been granted exclusive global rights to commercialise patented MicroMAX® microencapsulation technology by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) for use in the field of Animal Therapeutics.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding CannPal
Sign Up For FreeTo access detailed company insights
CannPal Animal Therapeutics is a global leader in developing cannabinoid-derived therapeutic products aimed at veterinarians and pet owners. The company focuses on creating clinically validated and standardized therapeutics for treating pain, inflammation, mood, and dermatological conditions in animals. As a subsidiary of AusCann Group Holdings, Ca... Read More
